第60回日本小児血液・がん学会学術集会

Session information

一般口演

第60回 日本小児血液・がん学会学術集会 » 一般口演

[_OS11] 一般口演11
脳腫瘍1

Oral Session 11 Brain tumor 1

Wed. Nov 14, 2018 10:50 AM - 11:50 AM 第6会場 (みやこめっせ B1F 特別展示場A)

座長:原 純一(大阪市立総合医療センター), 古賀 友紀(九州大学医学部医学研究院地域連携小児医療学講座)

Masahiro Sugawa1, Yuki Arakawa1, Torataro Takaki1, Jun Noguchi1, Masato Yanagi1, Kiyotaka Isobe1, Makiko Mori1, Jun Kurihara2, Eiji Oguma3, Atsuko Nakazawa4, Hiroshi Kishimoto5, Katsuyoshi Koh1 (1.Department of Hematology and Oncology, Saitama Children’s Medical Center, Saitama, Japan, 2.Department of Neurosurgery, Saitama Children’s Medical Center, Saitama, Japan, 3.Department of Radiology, Saitama Children’s Medical Center, Saitama, Japan, 4.Department of Clinical Resarch, Saitama Children’s Medical Center, Saitama, Japan, 5.Department of Diagnostic Pathology, Saitama Children’s Medical Center, Saitama, Japan)

Yoshiko Nakano1, Yuko Watanabe2, Taishi Nakamura3, Ryuta Saito4, Masayuki Kanamori4, Yasuhiro Matsusaka5, Noritsugu Kunihiro5, Keiko Okada6, Junichi Hara6, Hiroaki Sakamoto5, Koichi Ichimura1 (1.Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 2.Department of Pediatrics, Tohoku University School of Medicine, 3.Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 4.Department of Neurosurgery, Tohoku University Graduate School of Medicine, 5.Department of Pediatric Neurosurgery, Osaka City General Hospital, 6.Department of Pediatric Hematology/Oncology, Osaka City General Hospital)

Kai Yamasaki1, Yoshiko Nakano4, Kazuki Tanimura1, Kouta Hira1, Yuki Okuhiro1, Chika Nitani1, Keiko Okada1, Hiroyuki Fujisaki1, Noritsugu Kunihiro2, Yasuhiro Matsusaka2, Hiroaki Sakamoto2, Hiroko Fukushima3, Takeshi Inoue3, Koichi Ichimura4, Junichi Hara1 (1.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan, 2.Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan, 3.Department of Pathology, Osaka City General Hospital, Osaka, Japan, 4.Division of Brain Tumor Translational Research, National Cancer Research Institute, Tokyo, Japan)

Kai Yamasaki1, Yuko Watanabe2, Yuhki Koga3, Chikako Kiyotani4, Keita Terashima4, Hiroaki Goto5, Kiyotaka Isobe6, Katsuyoshi Koh6, Daiichiro Hasegawa7, Yoshiyuki Kosaka7, Junichi Hara1 (1.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan, 2.Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan, 3.Department of Pediatrics, Kyushu University, Fukuoka, Japan, 4.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 5.Department of Hematology and Oncology, Kanagawa Children’s Medical Center, Kanagawa, Japan, 6.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan, 7.Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 8.Department of Hematology and Oncology, Kobe Children’s Hospital, Hyogo, Japan)